University of Florida logo

University of Florida

North America, Florida, United States, Gainesville

Description

University of Florida offers a range of degree programs ranging from associate to doctoral and professional degrees in the various fields.

Investor Profile

University of Florida has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does University of Florida frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 1
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
PBM Capital Group
North America, Virginia, United States, Charlottesville
Co-Investments: 1
Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Co-Investments: 1
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Foundation Fighting Blindness
North America, Maryland, United States, Columbia
Co-Investments: 1
MF
North America, Virginia, United States, Charlottesville
Co-Investments: 1

What are some of recent deals done by University of Florida?

Atsena Therapeutics

Durham, North Carolina, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

BiotechnologyHealth CareTherapeutics
Series ADec 16, 2020
Amount Raised: $55,000,000
Atsena Therapeutics

Durham, North Carolina, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

BiotechnologyHealth CareTherapeutics
Series AApr 1, 2020
Amount Raised: $8,150,000